Global Gastroparesis Drugs Market to Reach US$ 8.2 Billion by 2028, Impelled by the Increasing Prevalence of Diabetes

April 12, 2022 | Healthcare

According to the latest report by IMARC Group, titled "Gastroparesis Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028," the global gastroparesis drugs market reached a value of US$ 6.2 Billion in 2022. Gastroparesis, or delayed gastric emptying, is a medical condition that causes partial paralysis of the stomach muscles. It triggers heartburn, nausea, vomiting of undigested food, abdominal bloating, early satiety, and problems in regulating blood sugar levels. At present, gastroparesis can be treated through the utilization of various therapeutic drugs, such as antiemetics, proton pump inhibitors (PPI’s), erythromycin, prochlorperazine and erythromycin. These medications assist in controlling nausea, reducing acid refluxes, and ensuring stomach contractions for further helping food move down through the digestive tract. On account of these properties, they are extensively used for treating diabetic, post-surgical and idiopathic gastroparesis diseases.

Global Gastroparesis Drugs Market Trends:

The global gastroparesis drug market is primarily driven by the increasing prevalence of diabetes, especially amongst the rising geriatric population. This can be attributed to the escalating consumption of tobacco-based products and alcoholic beverages. The growing number of laparotomy procedures that cause postsurgical gastroparesis syndrome (PGS) are further inflating the overall sales of gastroparesis drugs across the globe. In line with this, significant investments being made by the government bodies of several nations in the research and development (R&D) department of medical sciences to introduce novel antiemetic drug therapy and prokinetics medications are acting as other growth-inducing factors. These medicines assist in enhancing gastrointestinal mobility and treating idiopathic gastroparesis that causes upper abdominal pain. The market growth is also influenced by ongoing technological advancements that are focusing on developing effective drug delivery solutions, such as nasal cavity route of administration, with reduced discomfort and enhanced patient outcomes. Other factors, such as improving healthcare infrastructure, the growing demand for eco-friendly drugs and the increasing awareness amongst consumers regarding the availability of different treatment options, are creating a positive outlook for the market. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 8.2 Billion by 2028, growing at a CAGR of 5.05% during 2023-2028.

Market Summary:

Based on the disease type, the market has classified into diabetic, idiopathic, post-surgical gastroparesis, and others.
On the basis of the drug class, the market has been segregated into prokinetic agents, antiemetic agents, and botulinum toxin injections.
Based on the distribution channel, the market has been segmented into hospitals and clinics, pharmacies, and online stores.
On a regional basis, the market has beenbifurcated into North America (United States, and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and Others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and Others), Latin America (Brazil, Mexico, and Others), and Middle East and Africa.
The competitive landscape of the industry has also been examined, along with the profiles of the key players being Abbott Laboratories, Abbvie Inc., AstraZeneca Plc, Bausch Health Companies Inc., Becton Dickinson and Company, Boston Scientific Corporation, Evoke Pharma, Medtronic plc, Neurogastrx Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited and Theravance Biopharma.

Report Scope:

Report Features	Details
Base Year of the Analysis	2022
Historical Period	2017-2022
Forecast Period	2023-2028
Units	US$ Billion
Segment Coverage	Disease Type, Drug Class, Distribution Channel, Region
Region Covered	Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered	United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered	Abbott Laboratories, Abbvie Inc., AstraZeneca Plc, Bausch Health Companies Inc., Becton Dickinson and Company, Boston Scientific Corporation, Evoke Pharma, Medtronic plc, Neurogastrx Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited and Theravance Biopharma
Customization Scope	10% Free Customization
Report Price and Purchase Option	Single User License: US$ 2499 Five User License: US$ 3499 Corporate License: US$ 4499
Post-Sale Analyst Support	10-12 Weeks
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Need more help?

Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.

Global Gastroparesis Drugs Market to Reach US$ 8.2 Billion by 2028, Impelled by the Increasing Prevalence of Diabetes

Purchase options Year End sale

Single User License ~~$2499~~ $2249
Five User License ~~$3499~~ $2974
Corporate License ~~$4499~~ $3599

Inquire Before Buying

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Speak to an Analyst

Request Brochure

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.